UNSPSC 85761605: Revision of infusion device in respiratory tract, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of infusion device in respiratory tract, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0WWQ73Z

UNSPSC 85761605 Revision of infusion device in respiratory tract, via natural or artificial opening is a Commodity code that shows little relevant recent activity aligned with its nominal scope. The recent state and local opportunities tagged under this code concern occupational medical surveillance, independent medical evaluations for public safety pension determinations, surgical benefit carve-out programs, pharmacy benefit management, temporary health professional staffing, specialty medical services for detained youth, and emergency medical care—none of which involve respiratory tract infusion device revision or placement. The mismatch between the code's technical medical-device focus and the health services and benefit administration work actually being solicited suggests either tagging error or the code's current inactivity in state and local procurement.

Geographic representation across the opportunities spans Arizona (Phoenix), California (Long Beach and Santa Clara County), Washington State, and Texas (Harris County), with no meaningful concentration in any single region. Recent solicitations include the Washington State Department of Transportation's occupational medical surveillance RFP (proposals due October 9, 2026), the City of Phoenix Retirement Office's independent medical evaluation services RFP (proposals due October 16, 2026), the City of Long Beach's surgical benefit carve-out program RFP (proposals due October 7, 2026), and Santa Clara County Health System's temporary health professional staffing qualification vehicle (proposals due October 7, 2026). None of these opportunities directly relate to respiratory infusion device procurement or revision.